Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study
- PMID: 17339582
- DOI: 10.1212/01.wnl.0000256368.57375.b7
Serum cholesterol changes after midlife and late-life cognition: twenty-one-year follow-up study
Abstract
Background: Longitudinal studies have shown that high serum total cholesterol (TC) at midlife is a risk factor for dementia/Alzheimer disease. The significance of TC later in life is unclear.
Objective: To investigate changes in serum TC from midlife to late life and their relationship with late-life cognition.
Methods: Participants of the Cardiovascular Risk Factors, Aging and Dementia study were derived from random, population-based samples previously studied in a survey in 1972, 1977, 1982, or 1987. After an average follow-up of 21 years, 1,449 individuals aged 65 to 79 were reexamined in 1998.
Results: Serum TC levels decreased in most individuals. High midlife TC represented a risk factor for more severe cognitive impairment later in life, and the values were significantly different between the control, mild cognitive impairment, and dementia groups. There were no significant differences in serum TC at reexamination. A moderate decrease in serum TC from midlife to late life (0.5 to 2 mmol/L) was significantly associated with the risk of a more impaired late-life cognitive status, even after adjusting for age, follow-up time, sex, years of formal education, midlife cholesterol, changes in body mass index, APOE epsilon4 genotype, history of myocardial infarction/stroke/diabetes, and lipid-lowering treatment.
Conclusions: The relationship between serum total cholesterol (TC) and dementia seems to be bidirectional. High midlife serum TC is a risk factor for subsequent dementia/Alzheimer disease, but decreasing serum TC after midlife may reflect ongoing disease processes and may represent a risk marker for late-life cognitive impairment.
Similar articles
-
Serum total cholesterol, statins and cognition in non-demented elderly.Neurobiol Aging. 2009 Jun;30(6):1006-9. doi: 10.1016/j.neurobiolaging.2007.09.012. Epub 2007 Nov 19. Neurobiol Aging. 2009. PMID: 18022292 Clinical Trial.
-
Obesity and vascular risk factors at midlife and the risk of dementia and Alzheimer disease.Arch Neurol. 2005 Oct;62(10):1556-60. doi: 10.1001/archneur.62.10.1556. Arch Neurol. 2005. PMID: 16216938
-
Lipid metabolism in cognitive decline and dementia.Brain Res Rev. 2006 Aug;51(2):275-92. doi: 10.1016/j.brainresrev.2005.11.007. Epub 2006 Jan 10. Brain Res Rev. 2006. PMID: 16410024 Review.
-
Serum cholesterol and risk of Alzheimer disease: a community-based cohort study.Neurology. 2005 Oct 11;65(7):1045-50. doi: 10.1212/01.wnl.0000178989.87072.11. Neurology. 2005. PMID: 16217057
-
The epidemiologic study of dementia: a life-long quest?Neurobiol Aging. 2005 Mar;26(3):335-40. doi: 10.1016/j.neurobiolaging.2004.03.016. Neurobiol Aging. 2005. PMID: 15639311 Review.
Cited by
-
A Modified Mediterranean Ketogenic Diet mitigates modifiable risk factors of Alzheimer's Disease: a serum and CSF-based metabolic analysis.medRxiv [Preprint]. 2023 Nov 27:2023.11.27.23298990. doi: 10.1101/2023.11.27.23298990. medRxiv. 2023. Update in: NPJ Metab Health Dis. 2024;2(1):15. doi: 10.1038/s44324-024-00016-3 PMID: 38076824 Free PMC article. Updated. Preprint.
-
Mapping water exchange across the blood-brain barrier using 3D diffusion-prepared arterial spin labeled perfusion MRI.Magn Reson Med. 2019 May;81(5):3065-3079. doi: 10.1002/mrm.27632. Epub 2018 Dec 18. Magn Reson Med. 2019. PMID: 30561821 Free PMC article.
-
Effects of Sex on the Relationship Between Apolipoprotein E Gene and Serum Lipid Profiles in Alzheimer's Disease.Front Aging Neurosci. 2022 May 30;14:844066. doi: 10.3389/fnagi.2022.844066. eCollection 2022. Front Aging Neurosci. 2022. PMID: 35707700 Free PMC article.
-
RXRA gene variations influence Alzheimer's disease risk and cholesterol metabolism.J Cell Mol Med. 2009 Mar;13(3):589-98. doi: 10.1111/j.1582-4934.2009.00383.x. J Cell Mol Med. 2009. PMID: 19374686 Free PMC article.
-
Long-Term Increase in Cholesterol Is Associated With Better Cognitive Function: Evidence From a Longitudinal Study.Front Aging Neurosci. 2021 Jun 17;13:691423. doi: 10.3389/fnagi.2021.691423. eCollection 2021. Front Aging Neurosci. 2021. PMID: 34220488 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous